218 related articles for article (PubMed ID: 21106879)
21. Deuterium exchange and mass spectrometry reveal the interaction differences of two synthetic modulators of RXRalpha LBD.
Yan X; Pérez E; Leid M; Schimerlik MI; de Lera AR; Deinzer ML
Protein Sci; 2007 Nov; 16(11):2491-501. PubMed ID: 17905826
[TBL] [Abstract][Full Text] [Related]
22. Structure of the carboxy-terminal region of thyroid hormone nuclear receptors and its possible role in hormone-dependent intermolecular interactions.
Bhat MK; McPhie P; Ting YT; Zhu XG; Cheng SY
Biochemistry; 1995 Aug; 34(33):10591-9. PubMed ID: 7544615
[TBL] [Abstract][Full Text] [Related]
23. Two resistance to thyroid hormone mutants with impaired hormone binding.
Huber BR; Sandler B; West BL; Cunha Lima ST; Nguyen HT; Apriletti JW; Baxter JD; Fletterick RJ
Mol Endocrinol; 2003 Apr; 17(4):643-52. PubMed ID: 12554782
[TBL] [Abstract][Full Text] [Related]
24. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
Fratev F
Phys Chem Chem Phys; 2015 May; 17(20):13403-20. PubMed ID: 25927714
[TBL] [Abstract][Full Text] [Related]
25. Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.
Frego L; Davidson W
Protein Sci; 2006 Apr; 15(4):722-30. PubMed ID: 16600964
[TBL] [Abstract][Full Text] [Related]
26. Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor beta.
Nawaz Z; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11691-5. PubMed ID: 8524830
[TBL] [Abstract][Full Text] [Related]
27. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants.
Souza PC; Barra GB; Velasco LF; Ribeiro IC; Simeoni LA; Togashi M; Webb P; Neves FA; Skaf MS; Martínez L; Polikarpov I
J Mol Biol; 2011 Oct; 412(5):882-93. PubMed ID: 21530542
[TBL] [Abstract][Full Text] [Related]
28. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
Celik L; Lund JD; Schiøtt B
Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
[TBL] [Abstract][Full Text] [Related]
29. A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation.
Langlois MF; Zanger K; Monden T; Safer JD; Hollenberg AN; Wondisford FE
J Biol Chem; 1997 Oct; 272(40):24927-33. PubMed ID: 9312095
[TBL] [Abstract][Full Text] [Related]
30. The human transcription factor IID subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D(3) and thyroid hormone receptors.
Mengus G; Gangloff YG; Carré L; Lavigne AC; Davidson I
J Biol Chem; 2000 Apr; 275(14):10064-71. PubMed ID: 10744685
[TBL] [Abstract][Full Text] [Related]
31. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.
Pissios P; Tzameli I; Kushner P; Moore DD
Mol Cell; 2000 Aug; 6(2):245-53. PubMed ID: 10983973
[TBL] [Abstract][Full Text] [Related]
32. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
[TBL] [Abstract][Full Text] [Related]
33. Expression of the rat alpha 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity.
Apriletti JW; Baxter JD; Lau KH; West BL
Protein Expr Purif; 1995 Jun; 6(3):363-70. PubMed ID: 7663174
[TBL] [Abstract][Full Text] [Related]
34. HDX-MS reveals orthosteric and allosteric changes in apolipoprotein-D structural dynamics upon binding of progesterone.
Kielkopf CS; Ghosh M; Anand GS; Brown SHJ
Protein Sci; 2019 Feb; 28(2):365-374. PubMed ID: 30353968
[TBL] [Abstract][Full Text] [Related]
35. Hormone selectivity in thyroid hormone receptors.
Wagner RL; Huber BR; Shiau AK; Kelly A; Cunha Lima ST; Scanlan TS; Apriletti JW; Baxter JD; West BL; Fletterick RJ
Mol Endocrinol; 2001 Mar; 15(3):398-410. PubMed ID: 11222741
[TBL] [Abstract][Full Text] [Related]
36. Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor.
Spanjaard RA; Darling DS; Chin WW
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8587-91. PubMed ID: 1924318
[TBL] [Abstract][Full Text] [Related]
37. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor.
Ribeiro RC; Feng W; Wagner RL; Costa CH; Pereira AC; Apriletti JW; Fletterick RJ; Baxter JD
J Biol Chem; 2001 May; 276(18):14987-95. PubMed ID: 11145963
[TBL] [Abstract][Full Text] [Related]
38. Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5',5-triiodo-L-thyronine and inhibit homodimer formation.
Togashi M; Nguyen P; Fletterick R; Baxter JD; Webb P
J Biol Chem; 2005 Jul; 280(27):25665-73. PubMed ID: 15886199
[TBL] [Abstract][Full Text] [Related]
39. A novel role for helix 12 of retinoid X receptor in regulating repression.
Zhang J; Hu X; Lazar MA
Mol Cell Biol; 1999 Sep; 19(9):6448-57. PubMed ID: 10454590
[TBL] [Abstract][Full Text] [Related]
40. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
